Digital Pathology Slide Scanner Market Revenue to Attain USD 4.87 Bn by 2033

07 Aug 2025

Share :

Table of Content

1. Digital Pathology Slide Scanner Market Revenue and Trends 2025 to 2033 2. Market Overview 3. Segment Insights 4. Regional Insights 5. Digital Pathology Slide Scanner Market Coverage 6. Digital Pathology Slide Scanner Market Key Players

Digital Pathology Slide Scanner Market Revenue and Trends 2025 to 2033

The global digital pathology slide scanner market revenue was valued at USD 1.39 billion in 2025 and is expected to attain around USD 4.87 billion by 2033, growing at a CAGR of 16.95% during forecast period. The growth of the market is attributed to the increasing prevalence of cancer and the adoption of AI-driven diagnostic tools. The rising demand for remote pathology consultations also bolsters market growth.

Market Overview

The digital pathology slide scanner market is mainly fueled by the growing need for precise and prompt disease diagnostics, with a significant focus on oncology applications. Alongside the demand for accurate and timely diagnostics, there is a growing implementation of digital workflows within healthcare facilities. This shift is driven by the aim to enhance healthcare, specifically in pathology, to improve patient outcomes. The increasing use of AI-driven diagnostics provides greater precision, and telepathology offers real-time, remote consultation and expert opinion. Moreover, advancements in technology, such as higher resolution imaging and cloud-based storage, enhance usability and accessibility. In addition, the global increase in chronic diseases, an aging population, and policy frameworks supporting digital health implementation across various settings are likely to encourage more laboratories and hospitals to invest in slide scanners.

Segment Insights

• By product type, the brightfield slide scanners segment led the market in 2024. This is mainly due to affordability, superior image quality, and widespread application of brightfield slide scanners.
• By slide capacity, the medium-capacity slide scanners (101–300 slides) segment dominated the market in 2024. This is mainly due to their widespread applications, as they strike a balance between efficiency, speed, and cost-effectiveness.
• By technology, the whole slide imaging (WSI) segment dominated the market in 2024, driven by its accuracy, scalability, and diagnostic efficiency. The high throughput of WSI and its suitability for large-scale scanning make it a preferred choice in hospitals and laboratories.
• By application, the disease diagnosis segment led the market while holding a major share in 2024, driven by the increased demand for accurate, timely, and remote diagnostic solutions.
• By end-user, the hospitals & reference labs segment sustained dominance in the market in 2024, driven by increased number of patients undergoing diagnostics. Hospitals are considered the primary care settings, boosting patient volumes, which consequently boosts the demand for diagnostic solutions.
• By interface/integration, the integrated with LIS/KIMS/PACS segment led the market in 2024, as it streamlines workflow data flow with LIS/KIMS/PACS, enhancing accuracy.

Regional Insights

North America registered dominance in the digital pathology slide scanner market, capturing the largest share in 2024. The U.S. is a major contributor to the market due to its advanced healthcare infrastructure. The rapid expansion of telepathology services for remote consultation and the growth in companion diagnostics to support personalized medicine also bolstered the market in the region.

Meanwhile, Asia Pacific is emerging as the fastest-growing area due to rising government efforts to advance the healthcare system and increasing acceptance of digital healthcare solutions. The rising burden of cancer and increasing healthcare expenditure are likely to support regional market growth.

Digital Pathology Slide Scanner Market Coverage

Recent Development

• In April 2024, 3DHISTECH introduced the upgraded P480 2nd Generation Slide Scanner, enhancing its flagship model with improved scanning capabilities and workflow efficiencies, along with launching its 3DView software for 3D reconstructions and micro‑CT visualization, and securing MDSAP certification for Canada and Australia. (Source: https://www.3dhistech.com)
  

Digital Pathology Slide Scanner Market Key Players

• Leica Biosystems (Danaher Corporation)
• Philips Healthcare
• Hamamatsu Photonics
• 3DHISTECH Ltd.
• Roche (Ventana Medical Systems)
• Olympus Corporation
• Nikon Corporation
• Indica Labs
• Huron Digital Pathology
• OptraSCAN
• Mikroscan Technologies
• Epredia (formerly Thermo Fisher’s pathology division)
• Glencoe Software
• Visiopharm
• Sectra AB
• Akoya Biosciences
• Inspirata
• ContextVision
• PathAI
• Proscia Inc.

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6533

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com |+1 804 441 9344